Risk of Treatment-Related Toxicities from EGFR Tyrosine Kinase Inhibitors: A Meta-analysis of Clinical Trials of Gefitinib, Erlotinib, and Afatinib in Advanced EGFR -Mutated Non–Small Cell Lung Cancer

Details 詳細情報について

• CRID

  1360292619114154496

• DOI

  10.1016/j.jtho.2016.11.2236

• ISSN

  15560864

• Web Site

  https://api.elsevier.com/content/article/PII:S1556086416335821?httpAccept=text/xml

  https://api.elsevier.com/content/article/PII:S1556086416335821?httpAccept=text/plain

• Data Source

  • Crossref